US$ 23.63
bpc-157 safety fda status warning The just announced that they're taking steps to lift restrictions on 12 peptides — including and TB-500 — making them accessible through compounding pharmacies again. This is a HUGE step FDA takes coser look at
Description
Thats a weird thing to hear at 34

It was first described in the Journal of Physiology-Paris by Sikiri and colleagues in 1993

intracranial, portal, and caval hypertension
But the pathway exists for promising compounds to eventually become legal
